AAAAAA

   
Results: 1-21 |
Results: 21

Authors: Van der Looij, M Papp, J Sztan, M Pulay, T Elfadil, I Besznyak, I Toth, J Devilee, P Olah, E
Citation: M. Van Der Looij et al., Allelic imbalance and microsatellite instability in BRCA1 associated breast and ovarian tumors, INT J ONCOL, 18(4), 2001, pp. 775-780

Authors: Olah, E
Citation: E. Olah, Untitled - Edith Olah, EUR J CANC, 37(15), 2001, pp. 1809-1809

Authors: Orban, TI Olah, E
Citation: Ti. Orban et E. Olah, Purifying selection on silent sites - a constraint from splicing regulation?, TRENDS GEN, 17(5), 2001, pp. 252-253

Authors: Benko, I Kovacs, P Szegedi, I Megyeri, A Kiss, A Balogh, E Olah, E Kappelmayer, J Kiss, C
Citation: I. Benko et al., Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia, N-S ARCH PH, 363(5), 2001, pp. 499-508

Authors: Forster-Horvath, C Bocsi, J Raso, E Orban, TI Olah, E Timar, J Ladanyi, A
Citation: C. Forster-horvath et al., Constitutive intracellular expression and activation-induced cell surface up-regulation of CD44v3 in human T lymphocytes, EUR J IMMUN, 31(2), 2001, pp. 600-608

Authors: Orban, TI Olah, E
Citation: Ti. Orban et E. Olah, Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines, BIOC BIOP R, 280(1), 2001, pp. 32-38

Authors: van der Looij, M Cleton-Jansen, AM van Eijk, R Morreau, H van Vliet, M Kuipers-Dijkshoorn, N Olah, E Cornelisse, CJ Devilee, P
Citation: M. Van Der Looij et al., A sporadic breast tumor with a somatically acquired complex genomic rearrangement in BRCA1, GENE CHROM, 27(3), 2000, pp. 295-302

Authors: Beck, Z Kiss, A Toth, FD Szabo, J Bacsi, A Balogh, E Borbely, A Telek, B Kovacs, E Olah, E Rak, K
Citation: Z. Beck et al., Alterations of P53 and RB genes and the evolution of the accelerated phaseof chronic myeloid leukemia, LEUK LYMPH, 38(5-6), 2000, pp. 587-597

Authors: Orban, TI Csokay, B Olah, E
Citation: Ti. Orban et al., Sequence alterations can mask each other's presence during screening with SSCP or heteroduplex analysis: BRCA genes as examples, BIOTECHNIQU, 29(1), 2000, pp. 94

Authors: Van der Looij, M Szabo, C Besznyak, I Liszka, G Csokay, B Pulay, T Toth, J Devilee, P King, MC Olah, E
Citation: M. Van Der Looij et al., Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in hungary, INT J CANC, 86(5), 2000, pp. 737-740

Authors: Mazoyer, S Leary, J Kirk, J Fleischmann, E Wagner, T Claes, K Messiaen, L Foulkes, W Desrochers, M Simard, J Phelan, CM Kwan, E Narod, SA Vahteristo, P Nevanlinna, H Durando, X Bignon, YJ Peyrat, JP Bonnardel, C Sinilnikova, OM Puget, N Lenoir, GM Mazoyer, S Audoynaud, C Goldgar, D Maugard, C Caux, V Gad, S Stoppa-Lyonnet, D Nogues, C Lidereau, R Machavoine, C Bressac-de Paillerets, B Kuschel, B Betz, B Niederacher, D Beckmann, MW Hamann, U Gayther, SA Ponder, BAP Robinson, M Taylor, GR Bishop, T Catteau, A Solomon, E Cohen, B Steel, M Collins, N Stratton, M van der Looij, M Olah, E Miller, NJ Barton, DE Sverdlov, RS Friedman, E Radice, P Montagna, M Sensi, E Caligo, M van Eijk, R Devilee, P van der Luijt, R Heimdal, K Moller, P Borg, A Diez, O Cortes, J Domenech, M Baiget, M Osorio, A Benitez, J Borg, A Maillet, P Sappino, AP Ozdag, H Ozcelik, T Ozturk, M Rohlfs, EM Boyd, J McDermott, D Offit, K Unger, M Nathanson, K Weber, BL Sellers, TA Hampton, E Couch, FJ Neuhausen, S
Citation: S. Mazoyer et al., The exon 13 duplication in the BRCA1 gene is a founder mutation present ingeographically diverse populations, AM J HU GEN, 67(1), 2000, pp. 207-212

Authors: Laake, K Launonen, V Niederacher, D Gudlaugsdottir, S Seitz, S Rio, P Champeme, MH Bieche, I Birnbaum, D White, G Sztan, M Sever, N Plummer, S Osorio, A Broeks, A Huusko, P Spurr, N Borg, A Cleton-Jansen, AM van't Veer, L Benitez, J Casey, G Peterlin, B Olah, E Varley, J Bignon, YJ Scherneck, S Sigurdardottir, V Lidereau, R Eyfjord, J Beckmann, MW Winqvist, R Skovlund, E Borresen-Dale, AL
Citation: K. Laake et al., Loss of heterozygosity at 11q23.1 and survival in breast cancer: Results of a large European study, GENE CHROM, 25(3), 1999, pp. 212-221

Authors: Papp, J Raicevic, L Milasin, J Dimitrijevic, B Radulovic, S Olah, E
Citation: J. Papp et al., Germline mutation analysis of BRCA1 and BRCA2 genes in Yugoslav breast/ovarian cancer families, ONCOL REP, 6(6), 1999, pp. 1435-1438

Authors: Szappanos, L Olah, E Balogh, E Rasko, I Szeszak, F Szepesi, K
Citation: L. Szappanos et al., Is there any regulatory gene defect behind idiopathic scoliosis?, ST HEAL T, 59, 1999, pp. 321-324

Authors: Olah, E
Citation: E. Olah, Molecular cancer genetics in Eastern and Central Europe, DIS MARKER, 15(1-3), 1999, pp. 75-77

Authors: Tihomirova, L Csokay, B Stengrevics, A Sinicka, O Kamerade, R Olah, E
Citation: L. Tihomirova et al., Hereditary breast cancer in Latvia: Mutation analysis of the BRCA1 gene, DIS MARKER, 15(1-3), 1999, pp. 97-97

Authors: Morrison, PJ Steel, CM Vasen, HFA Eccles, D Evans, DGR Moller, P Hodgson, S Stoppa-Lyonnet, D Chang-Claude, J Caligo, M Olah, E Haites, NE Nevin, NC
Citation: Pj. Morrison et al., Insurance implications for individuals with a high risk of breast and ovarian cancer in Europe, DIS MARKER, 15(1-3), 1999, pp. 159-165

Authors: Jakab, Z Balogh, E Kiss, C Pajor, L Olah, E
Citation: Z. Jakab et al., Biclonal chromosomal aberrations in a child with myelodysplastic syndrome, CANC GENET, 108(1), 1999, pp. 13-18

Authors: Csokay, B Udvarhelyi, N Sulyok, Z Besznyak, I Ramus, S Ponder, B Olah, E
Citation: B. Csokay et al., High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history, CANCER RES, 59(5), 1999, pp. 995-998

Authors: Launonen, V Laake, K Huusko, P Niederacher, D Beckmann, MW Barkardottir, RB Geirsdottir, EK Gudmundsson, J Rio, P Bignon, YJ Seitz, S Scherneck, S Bieche, I Champeme, MH Birnbaum, D White, G Varley, J Sztan, M Olah, E Osorio, A Benitez, J Spurr, N Velikonja, N Peterlin, B Borg, A Cleton-Jansen, AM Devilee, P Bloigu, R Lidereau, R Borresen-Dale, AL Winqvist, R
Citation: V. Launonen et al., European multicenter study on LOH of APOC3 at 11q23 in 766 breast cancer patients: relation to clinical variables, BR J CANC, 80(5-6), 1999, pp. 879-882

Authors: Ribar, B Grallert, A Olah, E Szallasi, Z
Citation: B. Ribar et al., Deletion of the sep1(+) forkhead transcription factor homologue is not lethal but causes hyphal growth in Schizosaccharomyces pombe, BIOC BIOP R, 263(2), 1999, pp. 465-474
Risultati: 1-21 |